Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Impact of HFE gene Variants on Iron Overload, Overall Survival and Leukemia-Free Survival in Myelodysplastic Syndromes

Mathias A. Schneeweiss, Greiner Georg, MD PhD, Susanne Herndlhofer, Julia Schellnegger, Maria-Theresa Krauth, MD, Friedrich Wimazal, MD, Corinna Steinhauser, Renate Thalhammer, MD, Ilse Schwarzinger, MD, Harald Esterbauer, MD PhD, Manuela Födinger, Peter Valent, MD, Wolfgang R. Sperr, MD

Blood (2019) 134 (Supplement_1): 4269.

https://doi.org/10.1182/blood-2019-123390

Published: 2019

Journal Articles

KIT D816V Mutation Burden Predicts Prognosis and Survival In Patients With Mastocytosis and Correlates With The WHO Type Of The Disease

Gregor Hoermann, M.D., Ph.D., Karoline V. Gleixner, M.D., Graziella E. Dinu, B.Sc., Georg Greiner, Friedrich Wimazal, M.D., Emir Hadzijusufovic, DVM, Gerlinde Mitterbauer, M.D., Christine Mannhalter, Ph.D., Peter Valent, Wolfgang R Sperr, M.D.

Blood (2013) 122 (21): 4052.

https://doi.org/10.1182/blood.V122.21.4052.4052

Published: 2013

Journal Articles

Comorbidity as Prognostic Variable in MDS: Comparative Evaluation of the HCT-CI and CCI in a Core Data Set of 582 Patients of the Austrian MDS Platform.

Wolfgang R Sperr, Friedrich Wimazal, Michael Kundi, Christian Baumgartner, Thomas Noesslinger, Anabel Makrai, Reinhard Stauder, MD, Otto Krieger, Michael Pfeilstocker, MD, Peter Valent, MD

Blood (2008) 112 (11): 1648.

https://doi.org/10.1182/blood.V112.11.1648.1648

Published: 2008

Journal Articles

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

Detlef Haase, Ulrich Germing, Julie Schanz, Michael Pfeilstöcker, Thomas Nösslinger, Barbara Hildebrandt, Andrea Kundgen, Michael Lübbert, Regina Kunzmann, Aristoteles A. N. Giagounidis, Carlo Aul, Lorenz Trümper, Otto Krieger, Reinhard Stauder, Thomas H. Müller, Friedrich Wimazal, Peter Valent, Christa Fonatsch, Christian Steidl

Blood (2007) 110 (13): 4385–4395.

https://doi.org/10.1182/blood-2007-03-082404

Published: 2007

Includes: Supplemental data

Journal Articles

Prognostic Significance of Serial Determinations of LDH Levels in Primary ( De Novo ) Myelodysplastic Syndromes.

Friedrich Wimazal, MD, Wolfgang R. Sperr, MD, Anja Vales, MD, Michael Kundi, MD, Alexandra Boehm, MD, Renate Thalhammer, MD, Ilse Schwarzinger, MD, Peter Valent, MD

Blood (2006) 108 (11): 4828.

https://doi.org/10.1182/blood.V108.11.4828.4828

Published: 2006

Journal Articles

Clinical Course and Prognosis in Mast Cell Proliferative Disorders: A 17 Year Experience in a Single Center.

Wolfgang R. Sperr, MD, Friedrich Wimazal, MD, Alexandra Boehm, MD, Alexander W. Hauswirth, MD, Stefan Florian, Robert Fritsche-Polanz, MD, Manuela Foedinger, MD, Peter Valent, MD

Blood (2004) 104 (11): 4741.

https://doi.org/10.1182/blood.V104.11.4741.4741

Published: 2004

Journal Articles

The Influence of Age and Gender on the Prognostic Impact of Karytoypic Subgroups in Myelodysplastic Syndromes - a Multicenter Analysis.

Thomas Noesslinger, MD, Ulrich Germing, MD, PD, Barbara Hildebrandt, MD, Claudia Strupp, MD, Manuel Aivado, MD, Detlef Haase, MD, Julie Schanz, MD, Friedrich Wimazal, MD, Wolfgang Sperr, MD, Valent Peter, MD, Lubbert Michael, MD, PD, Otto Krieger, MD, Norbert Gattermann, MD, Aristoteles Giagounidis, MD, Heinz Tuchler, Rainer Haas, MD, Carlo Aul, MD, Michael Pfeilstocker, MD, PD

Blood (2004) 104 (11): 1448.

https://doi.org/10.1182/blood.V104.11.1448.1448

Published: 2004

Journal Articles

Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms

Puchit Samorapoompichit, Hans P. Kiener, Gerit-Holger Schernthaner, John-Hendrik Jordan, Hermine Agis, Friedrich Wimazal, Mehrdad Baghestanian, Abdolreza Rezaie-Majd, Wolfgang R. Sperr, Klaus Lechner, Peter Valent

Blood (2001) 98 (8): 2580–2583.

https://doi.org/10.1182/blood.V98.8.2580

Published: 2001

Journal Articles

The c-kit Ligand Stem Cell Factor and Anti-IgE Promote Expression of Monocyte Chemoattractant Protein-1 in Human Lung Mast Cells

Mehrdad Baghestanian, Roland Hofbauer, Hans P. Kiener, Hans C. Bankl, Friedrich Wimazal, Martin Willheim, Otto Scheiner, Wolfgang Füreder, Michael R. Müller, Dorian Bevec, Klaus Lechner, Peter Valent

Blood (1997) 90 (11): 4438–4449.

https://doi.org/10.1182/blood.V90.11.4438

Published: 1997

NARROW

Impact of HFE gene Variants on Iron Overload, Overall Survival and Leukemia-Free Survival in Myelodysplastic Syndromes

KIT D816V Mutation Burden Predicts Prognosis and Survival In Patients With Mastocytosis and Correlates With The WHO Type Of The Disease

Comorbidity as Prognostic Variable in MDS: Comparative Evaluation of the HCT-CI and CCI in a Core Data Set of 582 Patients of the Austrian MDS Platform.

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

Prognostic Significance of Serial Determinations of LDH Levels in Primary ( De Novo ) Myelodysplastic Syndromes.

Clinical Course and Prognosis in Mast Cell Proliferative Disorders: A 17 Year Experience in a Single Center.

The Influence of Age and Gender on the Prognostic Impact of Karytoypic Subgroups in Myelodysplastic Syndromes - a Multicenter Analysis.

Detection of tryptase in cytoplasmic granules of basophils in patients with chronic myeloid leukemia and other myeloid neoplasms

The c-kit Ligand Stem Cell Factor and Anti-IgE Promote Expression of Monocyte Chemoattractant Protein-1 in Human Lung Mast Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only